News from the FDA/CDC

Genital HPV prevalence tops 42% in adults


 

The overall prevalence of genital human papillomavirus (HPV) among adults aged 18-59 years was 42.5% in 2013-2014, with more than half of that representing infection with high-risk types, according to the National Center for Health Statistics.

Prevalence of the 14 HPV types (out of 37 total) considered to be high risk was almost 23% in 2013-2014. Men were significantly more likely than women to have any genital HPV (45% vs. 40%) and high-risk genital HPV (25% vs. 20%), the NCHS reported.

Prevalence of any/high-risk genital HPV in adults aged 18-59
There was significant variation by race and ethnicity. Black adults had the highest prevalence, with men at 65% for any genital HPV and 40% for high-risk genital HPV and women at 63% and 28%, respectively. Asian adults had the lowest rates, with men at 24% for any genital HPV and 12% for high-risk genital HPV and women at 23% and 12%, respectively, according to an analysis of penile and vaginal swab samples collected for the National Health and Nutrition Examination Survey.

Oral rinse samples were collected as well for adults aged 18-69 years, and the overall prevalence was 7.3% for any oral HPV and 4% for high-risk HPV in 2011-2014. Prevalence among men was significantly higher than among women for all oral HPV (11.5% vs. 3.3%) and for high-risk HPV (6.8% vs. 1.2%), the NCHS said.

Recommended Reading

Bioidentical hormone replacement fares well in phase III trial
MDedge ObGyn
Neoadjuvant chemotherapy induces mutational, molecular shifts in ovarian cancers
MDedge ObGyn
Confirmatory blood typing unnecessary for closed prolapse repairs
MDedge ObGyn
Predicting extraction of an intact uterus in robotic-assisted laparoscopic hysterectomy
MDedge ObGyn
Lightweight mesh reduces erosion risk after sacrocolpopexy
MDedge ObGyn
Updated embryo transfer recommendations promote singletons
MDedge ObGyn
Physicians favor ACOG mammography recommendations
MDedge ObGyn
Neurokinin receptor antagonist nearly halves hot flashes
MDedge ObGyn
Trump overturns Title X family planning rule
MDedge ObGyn
Liposomal bupivacaine cut need for opioids after gyn surgery
MDedge ObGyn